First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Up 275.0% in December

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,500 shares, a growth of 275.0% from the December 15th total of 400 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is presently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.4 %

NASDAQ FTXH traded up $0.11 during trading hours on Wednesday, hitting $26.99. The company’s stock had a trading volume of 4,427 shares, compared to its average volume of 1,392. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $25.73 and a twelve month high of $29.72. The firm has a market capitalization of $14.84 million, a P/E ratio of 15.98 and a beta of 0.70. The stock has a fifty day moving average of $27.65 and a 200 day moving average of $28.24.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th were given a dividend of $0.1304 per share. The ex-dividend date of this dividend was Friday, December 13th. This is a positive change from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.